Trial intelligence / Profile preview

Oxytocin for Alcohol Tolerance and Motivation

NCT05312008Phase 2Terminated

Sponsor
Indiana University
Start
Jan 2022
Primary completion
Dec 2023
Countries
1
01

Overview

A Phase 2 trial of oxytocin nasal spray in alcohol use disorder (AUD), sponsored by Indiana University. Started Jan 2022; status: terminated.

02

Drugs

oxytocin nasal spray
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT05312008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05312008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call